Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose atropine for myopia control in children
DRKS00023337Phase 3Active, not recruiting
- Sponsor
- Universitätsklinikum Freiburg
- Start
- Jun 2021
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atropine in myopia (2 arms), sponsored by Universitätsklinikum Freiburg. Started Jun 2021; status: active, not recruiting.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on DRKS00023337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00023337.